Search Results (1 to 10 of 3263 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 870 Journal of Medical Internet Research
- 602 JMIR Research Protocols
- 345 JMIR Formative Research
- 241 JMIR mHealth and uHealth
- 164 Online Journal of Public Health Informatics
- 158 JMIR Public Health and Surveillance
- 130 JMIR Medical Informatics
- 128 JMIR Mental Health
- 82 JMIR Human Factors
- 62 JMIR Cancer
- 53 JMIR Medical Education
- 47 JMIR Aging
- 42 JMIR Serious Games
- 41 JMIR Dermatology
- 41 JMIR Pediatrics and Parenting
- 37 JMIR Diabetes
- 36 Iproceedings
- 32 Interactive Journal of Medical Research
- 31 JMIR Cardio
- 22 JMIR Rehabilitation and Assistive Technologies
- 19 JMIR Infodemiology
- 19 JMIR Perioperative Medicine
- 17 JMIR AI
- 13 JMIRx Med
- 8 Journal of Participatory Medicine
- 7 JMIR Biomedical Engineering
- 5 JMIR Neurotechnology
- 3 JMIR Nursing
- 3 JMIR XR and Spatial Computing (JMXR)
- 2 JMIR Bioinformatics and Biotechnology
- 2 Medicine 2.0
- 1 JMIR Data
- 0 iProceedings
- 0 JMIR Preprints
- 0 JMIR Challenges
- 0 JMIRx Bio
- 0 Transfer Hub (manuscript eXchange)
- 0 Asian/Pacific Island Nursing Journal
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section

It was administered in doses ranging between 0.01 and 0.1 g/kg, 3 times daily either orally or intravenously (equivalent to 2.4-24 g/d for an 80 kg patient). Among patients with schizophrenia and catatonia, approximately 30 participants, the study showed a reduction of catatonic symptoms ranging from 60% to 70%. Specifically, there were improvements in anxiety, agitation, and restlessness.
JMIR Res Protoc 2025;14:e68356
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section

Example screenshots of the Study Management and Retention Tool (SMa RT) web application, including the different Combine intervention content sections: (A) log in screen, (B) study timeline, (C) intervention content home screen, (D), health resources section, (E) frequently asked questions about pre-exposure prophylaxis.
This section includes the major time points of the study (baseline, month 6, month 12, month 18, and month 24). It allows participants to see upcoming and previously completed surveys.
JMIR Res Protoc 2025;14:e69540
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section

To address the unique needs of veterans and civilians with COD and criminal legal involvement, an adaptation of MISSION, the criminal justice (MISSION-CJ) version was developed (Pinals, DA, unpublished manual, April 2014 and Smelson, D, unpublished manual, June 2014). MISSION-CJ is guided by the risk-need-responsivity framework of offender rehabilitation, which posits that rehabilitation should target “criminogenic needs” (ie, modifiable factors that are robust predictors of recidivism) [49,50].
JMIR Res Protoc 2025;14:e70750
Download Citation: END BibTex RIS

Natural Language Processing for Identification of Hospitalized People Who Use Drugs: Cohort Study
The presence of any of the following criteria (ie, abbreviated with the letters B, D, M, and N) were used to qualify the hospitalizations for inclusion in the PWUD cohort:
B (Biomarkers): In line with a previous study, positive urine toxicology for drugs or medications for SUD (eg, cocaine, amphetamine, methadone, suboxone, fentanyl, opiate, oxycodone), positive HCV antibody with positive or quantifiable HCV viral load [29]
D (Diagnostic codes): Presence of ICD-9 and or ICD-10 code for overdose, substance use
JMIR AI 2025;4:e63147
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section